FTO and central nervous system cancer: The low expression of FTO, the first m6A RNA-demethylase identified, was associated with poor outcomes in glioma (Xu et al., 2020), in line with our correlation analysis, which implied that m6A RNA modification might be directly or indirectly connected to inflammation in LGG, providing a certain reference value for our in-depth research or other people's research in the future.